Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ÇϺΠÁ÷Àå¾Ï¿¡¼­ °ý¾à±Ùº¸Á¸¼ú°ú º¹È¸À½ÀýÁ¦¼úÀÇ Àå±âÀû Á¾¾çÇÐÀû °á°ú The Long-term Oncological Outcome of a Sphincter-saving Resection and an Abdominoperineal Resection for Lower Rectal Cancer

´ëÇÑ´ëÀåÇ×¹®ÇÐȸÁö 2007³â 23±Ç 3È£ p.186 ~ 193
Á¤»óÈÆ, À¯Ã¢½Ä, ÃÖÆòÈ­, ±è´ëµ¿, È«µ¿Çö, ±èÈñö, ±èÁøõ,
¼Ò¼Ó »ó¼¼Á¤º¸
Á¤»óÈÆ ( Jung Sang-Hun ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç

À¯Ã¢½Ä ( Yu Chang-Sik ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ï¾Æ»êº´¿ø ¿Ü°úÇб³½Ç
ÃÖÆòÈ­ ( Choi Pyong-Wha ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ï¾Æ»êº´¿ø ¿Ü°úÇб³½Ç
±è´ëµ¿ ( Kim Dae-Dong ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ï¾Æ»êº´¿ø ¿Ü°úÇб³½Ç
È«µ¿Çö ( Hong Dong-hyun ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ï¾Æ»êº´¿ø ¿Ü°úÇб³½Ç
±èÈñö ( Kim Hee-Cheol ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ï¾Æ»êº´¿ø ¿Ü°úÇб³½Ç
±èÁøõ ( Kim Jin-Cheon ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ï¾Æ»êº´¿ø ¿Ü°úÇб³½Ç

Abstract


Purpose:The oncological safety of a sphincter-saving resection (SSR) in lower rectal cancer is widely accepted, and both an abdominoperineal resection (APR) and a SSR are used in potentially curative surgery. This retrospective study was performed to compare the long-term oncological outcomes after an APR and a SSR in patients with lower rectal cancer (within 5 cm from the anal verge).

Methods:We recruited 441 lower rectal cancer patients who underwent curative resections (APR: 305, SSR: 136) between 1995 and 2000. A total mesorectal excision and autonomic nerve preservation were routinely performed. The median follow- up period was 65 months.

Results: Most demographic findings were comparable between the groups; however, the APR groups revealed more advanced pathological characteristics (tumor depth, size, cell differentiation, and metastatic LN number). The local recurrence rates after an APR and a SSR were 12.8% and 7.4%, respectively (P= 0.09). An independent risk factor of local recurrence was LN metastasis only. Distant recurrence was higher in the APR group (26.4%) than in the SSR group (13.2%), but on multivariate analysis the difference was not significant (P=0.17). The 5-year cancer-specific survival rates after an APR and a SSR were 73.2% and 87.6%, respectively (P£¼0.05). Particularly, there was a significant survival difference for stage III patients (APR: 59.0% vs. SSR: 83.0%, P£¼0.05). However, an APR was not an indepen dent prognostic factor for cancer-specific survival in the multivariate analysis (P=0.07).

Conclusions:An APR per se did not influence local recurrence after a curative resection for lower rectal cancer. The poor cancer-specific survival in the stage III APR group might be attributed to increased distant metastasis due to its more distal location. J Korean Soc Coloproctol 2007;23:186-193

Å°¿öµå

°ý¾à±Ùº¸Á¸¼ú;º¹È¸À½ÀýÁ¦¼ú;Àç¹ß;»ýÁ¸À²
Sphincter-saving resection;Abdominoperineal resection;Recurrence;Survival rate

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS